These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16467013)

  • 1. Patient and physician characteristics in relation to clinical decision making in methadone maintenance treatment.
    Mitchell TB; Dyer KR; Peay ER
    Subst Use Misuse; 2006; 41(3):393-404. PubMed ID: 16467013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is methadone maintenance provided by private practitioners effective?].
    Stohler R; Nordt C; Falcato L; Dürsteler-MacFarland KM; Rössler W
    Soz Praventivmed; 2004; 49(4):276-80. PubMed ID: 15357530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.
    Lewis DC
    J Addict Dis; 1999; 18(2):5-21. PubMed ID: 10334372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pregnancy affect outcome of methadone maintenance treatment?
    Crandall C; Crosby RD; Carlson GA
    J Subst Abuse Treat; 2004 Jun; 26(4):295-303. PubMed ID: 15182894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance.
    Prosser JM; Steinfeld M; Cohen LJ; Derbyshire S; Eisenberg DP; Cruciani RA; Galynker II
    Drug Alcohol Depend; 2008 Jun; 95(3):237-44. PubMed ID: 18353568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance treatment can be provided in a primary care setting without increasing methadone-related mortality: the Sheffield experience 1997-2000.
    Keen J; Oliver P; Mathers N
    Br J Gen Pract; 2002 May; 52(478):387-9. PubMed ID: 12014536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic determinants of planned methadone treatment.
    Rivers PA; Dobalian A; Oyana TJ; Bae S
    Am J Health Behav; 2006; 30(5):451-9. PubMed ID: 16893307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.
    Elkin EB; Kim SH; Casper ES; Kissane DW; Schrag D
    J Clin Oncol; 2007 Nov; 25(33):5275-80. PubMed ID: 18024875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.